Showing results (801-810 of 809) with videos related to

Sort By:
Pageof 81
You have reached the last page of results.This site can display upto 809 results.
Eclinicalmedicine|November 17, 2025
Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trialYu-Chen Li, Xiao-Yun Li, Kai-Qi Lan, et al.
JAMA Oncology|March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialWang-Zhong Li, Xing Lv, Dan Hu, et al.
Journal of the National Cancer Institute|October 16, 2015
Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal CarcinomaLin-Quan Tang, Chao-Feng Li, Jing Li, et al.
JAMA|November 28, 2023
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical TrialHai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
Chinese Medical Journal|June 16, 2021
Delivery room resuscitation and short-term outcomes of extremely preterm and extremely low birth weight infants: a multicenter survey in North ChinaShuai-Jun Li, Qi Feng, Xiu-Ying Tian, et al.
BMC Medicine|November 28, 2023
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter studyTing Liu, Di Dong, Xun Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal CancerWei-Xiong Xia, Xing Lv, Hu Liang, et al.
The Lancet. Oncology|March 5, 2018
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialLin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.
The Journal of Clinical Investigation|January 2, 2025
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinomaYanni Zeng, Chun-Ling Luo, Guo-Wang Lin, et al.
Pageof 81